Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6233207 | 0.97 | DNM1 (0.41) | CA12CA1CA9TSHRLMNA | |
| Water SCHEMBL5077362 | 0.97 | CA12 (0.40) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL28756631 | 0.94 | DNM1 (0.48) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL10749508 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL9463621 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL10748735 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL5694373 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL10454324 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL10529077 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA | |
| SCHEMBL28072813 | 0.87 | DNM1 (0.55) | CA12CA1CA9TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3013352-B1 | MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES | CELICA BIOMEDICAL (SI) | 2018-09-05 | — | — | EP | claimed |
| US-20160139112-A1 | MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES | CELICA BIOMEDICAL (SI) | 2016-05-19 | — | — | US | claimed |
| EP-3013352-A1 | MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES | Celica BIOMEDICAL (SI) | 2016-05-04 | — | — | EP | claimed |
| WO-2014206948-A1 | MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES | CELICA D.O.O. (SI) | 2014-12-31 | — | — | WO | claimed |
| EP-2818177-A1 | Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states | Celica, D.O.O. (SI) | 2014-12-31 | — | — | EP | claimed |
| CN-112470045-B | Optical filter and display device | 住友化学株式会社 | 2023-08-08 | — | — | CN | disclosed |
| CN-112470045-A | Optical filter and display device | 住友化学株式会社 | 2021-03-09 | — | — | CN | disclosed |
| CN-112469695-A | Compound and method for producing same | 住友化学株式会社 | 2021-03-09 | — | — | CN | disclosed |
| WO-2020022134-A1 | COMPOUND AND METHOD FOR PRODUCING SAME | 住友化学株式会社 | 2020-01-30 | — | — | WO | disclosed |
| WO-2020022135-A1 | OPTICAL FILTER AND DISPLAY DEVICE | 住友化学株式会社 | 2020-01-30 | — | — | WO | disclosed |
| EP-3013352-B1 | MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES | CELICA BIOMEDICAL (SI) | 2018-09-05 | — | — | EP | disclosed |
| US-9970924-B2 | Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states | CELICA BIOMEDICAL (SI) | 2018-05-15 | — | — | US | disclosed |
| US-6828395-B1 | Polymerization process and control of polymer composition properties | UNIVATION TECHNOLOGIES, LLC | 2004-12-07 | — | — | US | disclosed |
| US-4931562-A | Piperidines | LION CORPORATION (JP) | 1990-06-05 | — | — | US | disclosed |
| US-4820437-A | MIXTURE OF HYDROGEN PEROXIDE AND NITROGEN CONTAINING HETEROCYCLIC ACTIVATORS | LION CORPORATION (JP) | 1989-04-11 | — | — | US | disclosed |
| EP-0071839-B1 | AROMATIC DIISOCYANATES HAVING N,N-DISUBSTITUTED SULFONAMIDO GROUPS, THEIR METHOD OF PREPARATION AND THEIR USE IN THE PREPARATION OF POLYURETHANES | BAYER AG (DE) | 1985-09-25 | — | — | EP | disclosed |
| US-4496491-A | Aromatic diisocyanates containing N,N-disubstituted sulfonamide groups and processes for their production | BAYER AKTIENGESELLSCHAFT (DE) | 1985-01-29 | — | — | US | disclosed |
| EP-0071839-A1 | Aromatic diisocyanates having N,N-disubstituted sulfonamido groups, their method of preparation and their use in the preparation of polyurethanes | BAYER AG (DE) | 1983-02-16 | — | — | EP | disclosed |
| US-4013758-A | PROCESS FOR PREPARING HYDRAZINES | OSBORG HANS | 1977-03-22 | — | — | US | disclosed |
| US-3966769-A | Sulfonyl compounds | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | disclosed |